8-K: Cadre Holdings Q3 2025: Sales Up 42%, TYR Tactical Acquired

Cadre Holdings reports robust third-quarter 2025 financial results with significant sales and profit growth, alongside a major acquisition and a new DoD contract.

Summary

• Net sales for the third quarter of 2025 reached $155.9 million, marking a 42% increase year-over-year.
• Gross profit for Q3 2025 was $66.6 million, up 66% compared to the prior year, with a gross profit margin of 42.7%.
• Net income for Q3 2025 stood at $10.9 million, or $0.27 per diluted share.
• Adjusted EBITDA for Q3 2025 was $29.8 million, significantly up from $13.5 million in Q3 2024, with an Adjusted EBITDA margin of 19.1%.
• Organic backlog increased by $20 million from Q2 2025 to Q3 2025.
• Cadre's subsidiary, Med-Eng, was awarded a $50 million Indefinite Delivery / Indefinite Quantity (IDIQ) contract by the U.S. Department of Defense (DoD) for the Blast Exposure Monitoring System (BEMO), with a first purchase order of $10 million to be shipped in 2026.
• The company agreed to acquire TYR Tactical, LLC, a leading manufacturer of tactical gear, for $175 million ($150 million cash and $25 million in CDRE stock), with the acquisition anticipated to close in the first half of 2026. TYR Tactical generated approximately $92.6 million in revenue in the year ended December 31, 2024.
• A quarterly cash dividend of $0.095 per share was declared in October 2025.
• Full-year 2025 guidance was reaffirmed, expecting net sales in the range of $624 million to $630 million and Adjusted EBITDA between $112 million and $116 million, with capital expenditures projected at $7 million to $8 million.

Sentiment

Score: 8

Explanation: Cadre Holdings delivered strong Q3 2025 financial results with significant growth in sales, gross profit, and Adjusted EBITDA, exceeding expectations. The strategic acquisition of TYR Tactical and the new DoD contract further strengthen its market position and future growth prospects. While debt levels have increased, the company's reaffirmed positive outlook and consistent dividend indicate robust operational health and strategic execution.

Positives

• Strong Q3 2025 net sales growth of 42% year-over-year to $155.9 million, driven by recent acquisitions and strong demand for armor and duty gear products.
• Gross profit increased 66% year-over-year to $66.6 million, with gross profit margin expanding by 610 basis points to 42.7%, primarily due to increased volume, favorable pricing, and decreased inventory step-up amortization.
• Adjusted EBITDA more than doubled year-over-year to $29.8 million, with Adjusted EBITDA margin improving by 670 basis points to 19.1%.
• Significant organic backlog increase of $20 million from Q2 to Q3, indicating robust future demand.
• Med-Eng secured a $50 million IDIQ contract with the DoD, with an initial $10 million purchase order for 2026 shipment, strengthening its position in the military market.
• Agreement to acquire TYR Tactical, a strategic acquisition expected to be immediately accretive to earnings and Adjusted EBITDA margins, adding $92.6 million in FY2024 revenue and providing significant entry into new markets, particularly European military and defense.
• Maintained consistent capital return to shareholders with a quarterly cash dividend of $0.095 per share.
• Reaffirmed strong full-year 2025 guidance for net sales ($624M-$630M) and Adjusted EBITDA ($112M-$116M), suggesting confidence in continued strong performance.

Negatives

• Total debt increased by $88.0 million from $223.2 million as of December 31, 2024, to $311.2 million as of September 30, 2025.
• Net debt increased by $62.1 million from $98.3 million as of December 31, 2024, to $160.4 million as of September 30, 2025.
• Interest expense, net, increased to $3.028 million in Q3 2025 from $1.991 million in Q3 2024.
• Selling, general and administrative expenses increased to $45.627 million in Q3 2025 from $33.981 million in Q3 2024.
• Restructuring and transaction costs increased to $2.216 million in Q3 2025 from $0.515 million in Q3 2024.
• Distribution segment gross margin slightly decreased to 21.3% in Q3 2025 from 21.9% in Q3 2024.

Risks

• Forward-looking statements are not guarantees, and actual results could differ materially from those expressed or implied due to various risks and uncertainties.
• Potential risks and uncertainties are more fully described in the Company's public reports filed with the Securities and Exchange Commission, including under the section titled Risk Factors in the Company's Annual Report on Form 10-K, and/or Quarterly Reports on Form 10-Q, as well as in Current Reports on Form 8-K.

Future Outlook

Cadre Holdings reaffirms its full-year 2025 guidance, expecting net sales in the range of $624 million to $630 million and Adjusted EBITDA between $112 million and $116 million. Capital expenditures are projected to be in the range of $7 million to $8 million. The company anticipates continued growth driven by attractive end markets and consistent execution.

Management Comments

• "We are pleased to report another quarter of strong performance, driven by Cadre's industry leading brands and favorable trends across our law enforcement, first responder, military, and nuclear end-markets."
• "Our teams delivered results above expectations, while expanding our backlog significantly and advancing Cadre's track record of consistent and stable growth despite a dynamic operating environment."
• "Revenue, gross profit, net income, and Adjusted EBITDA increased significantly this quarter, with an Adjusted EBITDA margin that improved 670 basis points year-over-year."
• "Our recently announced agreement to acquire TYR Tactical marks Cadre's sixth and largest acquisition since going public and a meaningful step forward in strengthening our diversified platform of durable safety businesses."
• "Cadre's disciplined M&A program is crucial to accelerating long-term growth, and we are excited to have once again delivered on our pledge to capitalize on attractive inorganic opportunities."
• "Building on our current momentum, we remain focused on pursuing additional transactions in line with our highly selective key criteria and continuing to take advantage of the free cash flow generated by the strong and recurring demand for our mission-critical safety and survivability equipment."

Industry Context

Cadre Holdings operates within favorable long-term industry tailwinds, including a commercial nuclear energy renaissance, ongoing national defense initiatives, and environmental management for nuclear cleanup. Public safety trends, such as significant investments in border patrol and ICE by the current administration, also support demand. While geopolitical conflicts present challenges for unexploded ordnance cleanup, the company's strong brand and premium products maintain consumer holster demand despite a general downturn in handgun sales. Successful new product launches over the past 24 months continue to provide customers with new options in the market.

Comparison to Industry Standards

• Med-Eng is highlighted as an industry expert and market leader in protection from blasts and explosive threats, with four decades of experience in evaluating blast effects and developing wearable blast sensors.
• TYR Tactical is described as a leading global manufacturer of tactical gear and equipment, possessing world-class engineering capabilities and global reach.
• TYR Tactical serves a worldwide customer base, including top-tier special operations units, government agencies, and militaries, indicating a strong competitive position.
• The minimal customer overlap between TYR Tactical and Cadre's existing Safariland Armor business suggests the acquisition will expand market share and customer wallet share rather than cannibalize existing business.

Related Party Transactions

• Restructuring and transaction costs for the nine months ended September 30, 2025, include a $1.0 million fee paid to Kanders & Company, Inc. for services related to the acquisition of Zircaloy.
• Restructuring and transaction costs for the nine months ended September 30, 2024, include a $1.8 million fee paid to Kanders & Company, Inc. for services related to the acquisition of Alpha Safety.

Stakeholder Impact

• Shareholders: Benefit from strong financial performance, strategic growth through accretive acquisitions, consistent dividend payments ($0.095 per share), and potential for increased share value.
• Employees: Potential for growth and integration opportunities with the TYR Tactical acquisition, expanding the company's global footprint and capabilities.
• Customers: Enhanced product offerings and capabilities through the TYR Tactical acquisition and continued innovation in mission-critical safety equipment, including new blast exposure monitoring systems from Med-Eng.
• Creditors: Increased debt levels, but strong Adjusted EBITDA and cash flow generation provide a solid basis for debt servicing.
• Government Agencies (DoD, Law Enforcement, First Responders): Continued supply of critical safety and survivability equipment, reinforced by new contracts and expanded product lines.

Next Steps

• Closing of the TYR Tactical acquisition, anticipated in the first half of 2026.
• Shipment of the first $10 million purchase order from the DoD contract in 2026.
• Management will host a conference call on November 5, 2025, to discuss the latest corporate developments and financial results.
• Continue to actively evaluate a pipeline of M&A opportunities in line with highly selective key criteria.
• Declaration of any future dividends is subject to the discretion of the Company's Board of Directors.

Key Dates

Recommendation

Cadre Holdings demonstrates exceptional operational execution with significant year-over-year growth in net sales, gross profit, and Adjusted EBITDA, exceeding expectations. The strategic acquisition of TYR Tactical, the largest since going public, is immediately accretive and expands market reach, particularly into European military and defense. The $50 million DoD contract further solidifies its position in critical defense sectors. Despite an increase in debt to fund growth, the company's strong free cash flow generation, consistent dividend, and reaffirmed positive full-year guidance indicate robust financial health and a clear growth trajectory. These factors, combined with favorable industry tailwinds, make Cadre Holdings a compelling investment opportunity.

Keywords

Safety equipment, Law enforcement, First responder, Military, Nuclear market, Body armor, EOD equipment, Duty gear, Tactical gear, Acquisitions, Financial results, Q3 2025, Cadre Holdings, CDRE, Med-Eng, TYR Tactical, Department of Defense, Government contracts